Title: Change in 21‐gene Recurrence Score result after exposure to neo‐adjuvant endocrine therapy in patients with operable breast cancer
Abstract: The Breast JournalVolume 26, Issue 7 p. 1449-1451 COMMENTARY Change in 21-gene Recurrence Score result after exposure to neo-adjuvant endocrine therapy in patients with operable breast cancer Talal Hilal MD, Talal Hilal MD orcid.org/0000-0001-8249-4128 Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorLanyu Mi MS, Lanyu Mi MS Department of Health Sciences Research, Biostatistics, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorNatalie M. Ertz-Archambault MD, Natalie M. Ertz-Archambault MD Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorDaniel R. Almquist MD, Daniel R. Almquist MD Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorKaren S. Anderson MD, PhD, Karen S. Anderson MD, PhD Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorRichard J. Gray MD, Richard J. Gray MD Department of Surgery, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorBarbara A. Pockaj MD, Barbara A. Pockaj MD Department of Surgery, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorDonald W. Northfelt MD, Donald W. Northfelt MD Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this author Talal Hilal MD, Talal Hilal MD orcid.org/0000-0001-8249-4128 Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorLanyu Mi MS, Lanyu Mi MS Department of Health Sciences Research, Biostatistics, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorNatalie M. Ertz-Archambault MD, Natalie M. Ertz-Archambault MD Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorDaniel R. Almquist MD, Daniel R. Almquist MD Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorKaren S. Anderson MD, PhD, Karen S. Anderson MD, PhD Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorRichard J. Gray MD, Richard J. Gray MD Department of Surgery, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorBarbara A. Pockaj MD, Barbara A. Pockaj MD Department of Surgery, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this authorDonald W. Northfelt MD, Donald W. Northfelt MD Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, ArizonaSearch for more papers by this author First published: 26 December 2019 https://doi.org/10.1111/tbj.13731 Correspondence Talal Hilal, MD, Division of Hematology and Medical Oncology, Mayo Clinic, 5777 East Mayo Blvd, Phoenix, AZ 85054, USA. Email: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume26, Issue7July 2020Pages 1449-1451 RelatedInformation